Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJX87
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,903
Award facts
- Contract value 100% obligated
- $16,902.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $16,902.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors, a pharmaceutical product used to treat autoimmune conditions such as psoriasis and rheumatoid arthritis. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems through the DLA Medical Supply Chain. The company holds a significant $999,999,999.00 IDC (SPE2DX) with DLA Troop Support Medical running through December 2026, which enables the delivery of a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. This delivery order for Cosentyx represents one of numerous pharmaceutical fulfillments under this prime contract vehicle, demonstrating AmerisourceBergen's role as a critical vendor for federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJX87?
SPE2DB25FJX87 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FJX87 worth?
The government has obligated $16,903 on SPE2DB25FJX87.
Is contract SPE2DB25FJX87 an order under another contract?
Yes. SPE2DB25FJX87 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJX87 competed?
The extent of competition for SPE2DB25FJX87 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award